REQUEST A DEMO
Total
USD $0.00
Search more companies

Epifarm OOO (Эпифарм ООО) (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Epifarm OOO Profile Updated: October 17, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Epifarm OOO (Эпифарм ООО) is a company based in Russia, with its head office in Crimea Republic. It operates in the Pharmacies and Drug Stores industry. It was established on February 05, 2015. The company’s latest financial report indicates a net sales revenue increase of 0.75% in 2025. There was a total growth of 18.45% in Epifarm OOO (Эпифарм ООО)’s total assets over the same period.

Headquarters
Vilino, Balatuk, 9
Crimea Republic; Crimea Republic; Postal Code: 298433

Contact Details: Purchase the Epifarm OOO (Эпифарм ООО) report to view the information.

Basic Information
Registered Capital:
Purchase the Epifarm OOO (Эпифарм ООО) report to view the information.
Financial Auditors:
Purchase the Epifarm OOO (Эпифарм ООО) report to view the information.
Incorporation Date:
February 05, 2015
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Epifarm OOO (Эпифарм ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
0.75%▲
Total Operating Revenue
0.75%▲
Operating Profit
N/A
Net Profit/Loss for the Period
N/A
Total Assets
18.45%▲
Total Equity
22.26%▲
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.11%▲
Cash Ratio
0.16%▲

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?